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ImmunohistochemistryTo maintain reliable signal transmission across a synapse, free synaptic neurotransmitters must be
removed from the cleft in a timely manner. In the ﬁrst visual synapse, this critical task is mainly under-
taken by glutamate transporters (EAATs). Here we study the differential roles of the EAAT1, EAAT2 and
EAAT5 subtypes in glutamate (GLU) uptake at the photoreceptor-to-depolarizing bipolar cell synapse
in intact dark-adapted retina. Various doses of EAAT blockers and/or GLU were injected into the eye
before the electroretinogram (ERG) was measured. Their effectiveness and potency in inhibiting the
ERG b-wave were studied to determine their relative contributions to the GLU clearing activity at the syn-
apse. The results showed that EAAT1 and EAAT2 plays different roles. Selectively blocking glial EAAT1
alone using UCPH101 inhibited the b-wave 2–24 h following injection, suggesting a dominating role of
EAAT1 in the overall GLU clearing capacity in the synaptic cleft. Selectively blocking EAAT2 on photore-
ceptor terminals had no signiﬁcant effect on the b-wave, but increased the potency of exogenous GLU in
inhibiting the b-wave. These suggest that EAAT2 play a secondary yet signiﬁcant role in the GLU reuptake
activity at the rod and the cone output synapses. Additionally, we have veriﬁed our electrophysiological
ﬁndings with double-label immunohistochemistry, and extend the literature on the spatial distribution
of EAAT2 splice variants in the mouse retina.
 2014 Elsevier Ltd. All rights reserved.1. Introduction
Glutamate is the neurotransmitter used by the ﬁrst synapse in
the retina (Copenhagen & Jahr, 1989; Massey, 1990; Massey &Redburn, 1987). L-glutamate (GLU) is tonically released at a high
rate in the dark by photoreceptors (Copenhagen & Jahr, 1989;
Dowling & Ripps, 1973) and activates postsynaptic receptors on
second-order neurons. Photoreceptors hyperpolarize in light
(Baylor & Fuortes, 1970), resulting in decreased vesicular GLU
release, which modulates synaptic input to bipolar and horizontal
cells (Attwell, 1990; Cervetto & MacNichol, 1972; Murakami et al.,
1975).
To ensure reliable signal transmission, synaptic GLU concentra-
tion must be regulated by quick removal of free GLU from the cleft.
This is the classical role of excitatory amino acid transporters
(EAATs), and is a two-step process. The transport turnover rate
for GLU of the EAATs was found to be very slow (Wadiche et al.,
1995b), but the EAATs have high afﬁnity to GLU (Diamond &
Jahr, 1997) and are present at presynaptic terminals at high-den-
sity (Hasegawa et al., 2006). Therefore, it is suggested that they
clear free synaptic GLU in a way resembling a buffer (Tong &
Jahr, 1994) instead of just a transporter. In the retina, glutamate
not reabsorbed by the presynaptic EAATs is thought to be removed
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transporting into the Muller cell via its membrane EAAT1 and con-
version into glutamine before transporting back to the photorecep-
tors (Hertz et al., 1999).
To date, ﬁve subtypes of EAATs have been identiﬁed in the
mammalian central nervous system (Danbolt, 2001; Shigeri et al.,
2004), namely EAAT1 to EAAT5. In retina, EAAT1 has been found
on Müller cells in rat (Rauen et al., 1996). EAAT2, also named
GLT1, was found on rod and cone terminals in rat (Rauen &
Kanner, 1994) and mouse (Haverkamp & Wassle, 2000), but sur-
prisingly not in mammalian Müller cells. GLT1 was further charac-
terized as splice variants GLT1A, located in rod spherules, and
GLT1B, in cone pedicles and some bipolar cells in rat (Reye et al.,
2002). EAAT3 was found to be present on the horizontal cells, ama-
crine cells and ganglion cells in the rat (Rauen et al., 1996; Schultz
& Stell, 1996). EAAT4 was found to be present on the Müller cells
and astrocytes in rat retina (Ward et al., 2004). EAAT5 has been
shown to be present on presynaptic rod terminals in the mouse
(Hasegawa et al., 2006; Wersinger et al., 2006).
The objectives of the present study are to determine the differ-
ential roles of EAAT2, EAAT1 and EAAT5 in the signal inputs of
depolarizing retinal bipolar cells (DBCs). The primary research
hypothesis is that the above EAATs are responsible for the
uptake/binding of free synaptic GLU in the outer plexiform layer
and that pharmacologically inhibiting them would disrupt signal
transmission between the photoreceptors and DBCs. Several spe-
ciﬁc and non-speciﬁc EAAT blockers are injected and their poten-
cies in inhibiting the ERG b-wave (which originates from DBCs)
were studied in intact dark-adapted mouse retina.
Our baseline data showed that the synthetic glutamate ana-
logue (LAP4) was more potent than GLU in inhibiting the ERG b-
wave when injected intravitreally. There is a possibility that the
difference in their potencies was because extracellular free GLU
but not LAP4 was being removed by EAATs at the photoreceptor-
to-DBC synapses. Therefore, our research hypothesis is that the
effect of extracellular GLU in saturating DBC signal transmission
is inﬂuenced by the GLU clearing activities of EAATs. GLU was
co-injected with EAAT blockers and the altered GLU potency in
inhibiting the ERG b-wave was determined in intact dark-adapted
retina.
The measured potencies of injected EAAT blockers and GLU
under different conditions have shed light on the GLU clearing
functions of various EAATs on the endogenous synaptic glutamate
equilibrium. That was achieved by taking advantage of an infrared
guided drug injection system and ERG recording techniques in
total darkness. Such an approach is advantageous over others
because it is more physiological as all in-vivo ﬂuid ﬂow and trans-
porter systems in the eye are intact and functional. Also, the synap-
tically released glutamate would not be washed out by the
perfused buffer as reported under in-vitro conditions (Winkler
et al., 1999), and any possible confounding global side-effects from
permanently knocking out the EAATs (Rothstein et al., 1996;
Tanaka et al., 1997; Watase et al., 1998) could be avoided. In the
second half of the study, we have conﬁrmed our electrophysiolog-
ical ﬁndings by double immunohistochemistry staining and
extended the literature on the spatial distribution of EAAT2 splice
variants in the mouse retina.2. Materials and methods
2.1. Animals
One hundred and twenty-three Wildtype mice (C57BL/6) from
Jackson Laboratories (Bar Harbor, ME) between 8 and 12 weeks
old were used for experiments. Animals were treated in accordancewith NIH guidelines and the Baylor College of Medicine IACUC wel-
fare guidelines which complied with The Code of Ethics of the
World Medical Association (Declaration of Helsinki) for experi-
ments involving humans.
2.2. Intravitreal injection
Solutions containing glutamate (Cat. no. g1626, Sigma–Aldrich,
St. Louis, MO), LAP4 (Cat. no. 0103, Tocris bioscience, Minneapolis,
MN), dihydrokainic acid (Cat. no. 0111, Tocris bioscience) or TBOA
(Cat. no. 1223, Tocris bioscience) were prepared by dissolving in
sterile Balanced Salt Solution (Alcon, Fort Worth, TX). Solution con-
taining UCPH (Cat. no. 3490, Tocris bioscience) was prepared by
dissolving in Dimethyl sulfoxide (DMSO, Sigma–Aldrich). Unless
otherwise stated, drug concentrations presented in the results
were vitreal/retinal concentrations calculated assuming that the
injected solution was diluted by 20 lL of vitreous (Gao et al.,
2006; Saszik et al., 2002).
Mice were ﬁrst dark-adapted for a minimum of 2 h. Prior to
intra-vitreal injection, mice were anaesthetized with weight-based
intraperitoneal injection of solution containing ketamine (46 mg/
ml), xylazine (9.2 mg/ml), and acepromazine (0.77 mg/ml). After
that, a single drop of 0.5% proparacaine hydrochloride, 1% tropica-
mide, and 2.5% phenylephrine was applied on the cornea for topi-
cal anesthesia and pupil mydriasis under dim red light. The
injection procedure was performed under infrared illumination.
First, a 32-gauge disposable needle was used to puncture the eye
at the pars planar. Solutions containing the drug or the control
were then injected in one eye using a NanoFil microinjection sys-
tem (World Precision Instrument, FL) into the vitreous chamber
through the puncture with a 34-gauge blunt needle visible behind
the dilated pupil. The needle was allowed to stay for an additional
30 s in the eye after the injection to avoid any injected drug from
escaping the eye when the needle was withdrawn. The volume of
ﬂuid injected was 1 lL for saline based drug, or 0.2 lL for DMSO
based drug.
2.3. Electroretinogram
Immediately after intravitreal injection, mice were placed on a
stereotaxic platform with their body temperature maintained at
39 C using a heating pad. Reference and ground electrodes were
placed in the forehead and tail, respectively. A blunt platinum nee-
dle active electrode was placed in contact with the center of each
cornea. Then a drop of methylcellulose gel (2.5%) was applied to
the eye. The platform was then placed inside a Ganzfeld dome
coated with highly reﬂective white paint (Munsell Paint, New
Windsor, NY) and the mice were then allowed to remain in
complete darkness for 3 min before recording.
All scotopic stimuli were generated using light emitting diodes
as half millisecond square pulse of 505 nm peak wavelength. A sco-
topic ERG protocol comprised of progressively increasing stimuli
strength was implemented to measure a- and b-waves in different
zones as deﬁned previously (Abd-El-Barr et al., 2009) to facilitate
dissection of the rod and cone pathways. Saturating stimuli were
generated with 1500 W xenon ﬂash bulbs (Novatron, Dallas, TX)
and attenuated with apertures and diffusers at the end of the sco-
topic protocol. All ﬂashes were calibrated with a photometer
(ILT1700 International Light, MA) and converted to the unit photo-
isomerizations/rod (R*/Rod), where 1 scot cd m2 = 581 photoiso-
merization/rod/s (Lyubarsky et al., 2004; Saszik et al., 2002). To
study the time course for the effect of the injected drugs, the above
protocol, which lasted 11 min, was implemented 4 times in the
ﬁrst hours following the injection.
ERG signals were ampliﬁed using Grass P122 ampliﬁers (band-
pass 0.1–1000 Hz; Grass Instruments, West Warwick, RI) and then
Table 1
Primary antibodies/lectin used in this study.
Antigen Dilution Host, type Source Catalog no. Immunogen
Calbindin 1:1000 Rabbit,
polyclonal
Millipore (Billerica, MA) AB1778 Recombinant mouse calbindin
GLT1A 1:500 Guinea pig
polyclonal
LifeSpan Bioscience Inc. (Seattle, WA) LS-C15448 A synthetic peptide corresponding to amino acids 554–573 from
the carboxy-terminus of rat GLT-1A
GLT1B 1:100 Mouse,
monoclonal
Abcam plc (Cambridge, MA); Novus
Biologicals, LLC (Littleton, CO)
Ab61859;
NB110-58775
A synthetic peptide made to a C-terminal region within resides
548–562 of rat GLT1B
Goa 1:500 Mouse,
monoclonal
Chemicon International (Temecula, CA) MAB3073 Puriﬁed bovine brain Goa
1:200 Rabbit,
polyclonal
Santa Cruz Biotechnology (Santa Cruz,
CA)
Sc-387 A synthetic peptide corresponding to an internal region of Goa of
rat origin
PKCa 1:1000 Rabbit,
polyclonal
Sigma–Aldrich Co. LLC (St. Louis, MO) P4334 Synthetic peptide corresponding to amino acids 659–672 from the
C-terminal variable (V5) region of rat PKCa
1:250 Mouse,
monoclonal
BD Transduction Lab. (San Jose, CA) 610107 Human PKCa aa. 270–427 Recombinant Protein
PSD95 1:100 Rabbit,
polyclonal
Abcam plc (Cambridge, MA) Ab18258 Synthetic peptide conjugated to KLH derived from within residues
50–150 of Mouse PSD95
Peanut agglutinin 1:50 –
Vector Laboratories Inc. (Burlingame, CA) FL-1071 –
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(USB-6216, National Instruments, TX). Signal averaging was
employed to increase the signal-to-noise ratio of recorded ERG
using custom codes written in Matlab (The MathWorks, Natick,
MA). 25 Responses were averaged with an interval of 2 s between
each ﬂash at the lowest intensity. Fewer responses were averaged
with a longer interval between ﬂashes as the intensity of the ﬂash
increased. The scotopic b-wave was digitally ﬁltered using the
‘‘ﬁltﬁlt’’ function (low-pass ﬁltered; Fc = 60 Hz) in Matlab to
remove oscillatory potentials before ﬁtting. Dose–response curves
showing the amplitude of b-wave against drug concentration were
ﬁtted using the DoseRep function of OriginPro v8.6 (OriginLab
Corp., Northampton, MA) pharmacology toolbox. Statistical com-
parison between groups in this study was calculated using
unpaired t-test, or one-way ANOVA with Tukey post-hoc analysis.
Signiﬁcant difference was deﬁned as p < 0.05 unless otherwise sta-
ted. ERG data presented in this report are normalized to compen-
sate for the effect from injecting the solvents (described in detail
in Section 3.1 of the companion paper). For example, the normal-
ized b-wave amplitude for the GLU injected group was calculated
using the following equation:
normalized amplitudeGLU ¼
amplitudeGLU injected eye
amplitudeuninjected fellow eye
Mean amplitudeuninjected control eyes
Mean amplitudesaline injected eyes
ð1Þ2.4. Antibody characterization
The following antibodies were acquired from commercial sup-
pliers for labeling speciﬁc cell types of the retina (Table 1). Hori-
zontal cells were immuno-labeled with a mouse monoclonal
antibody against calbindin (de Melo et al., 2003). Anti-GLT1A and
Anti-GLT1B antisera were purchased from LifeSpan Bioscience
(Seattle, WA) and Abcam plc (Cambridge, MA), respectively. The
antiserum has been shown to label neurons in the CA1 region of
the rat hippocampus (Rose et al., 2009). ON-cone bipolar cells
and rod bipolar cells were immuno-stained with a mouse mono-
clonal or a rabbit polyclonal antibody against G-protein Goa
(Haverkamp & Wassle, 2000). Rod bipolar cells were immuno-
labeled with rabbit and mouse antibodies against PKCa (Zhang
et al., 2005). Rod photoreceptor spherules were labeled with
anti-PSD95 antibody (Oh et al., 2007). Fluorescein tagged peanut
agglutinin (PNA) was used to stain cone pedicles (Blanks &
Johnson, 1983).2.5. Tissue preparation and immunohistochemistry
Mice were deeply anaesthetized when the eyes were enucle-
ated, and then immediately euthanized by an overdose of anesthe-
sia. The eyes were then dissected carefully to isolate whole retina,
which was subsequently ﬁxed in 4% paraformaldehyde (Electron
Microscopy Science, Fort Washington, PA) in phosphate buffer
(DPBS, Invitrogen, La Jolla, CA), pH 7.4, at room temperature for
45 min. IHC was performed using an indirect antibody method.
Retinae were cut into vertical sections 40 lm in thickness using
a vibratome. Sections were dephosphorylated by incubating over-
night with alkaline phosphatase as described previously (Reye
et al., 2002), and subsequently blocked with 10% donkey serum
(Jackson Immunoresearch, West Grove, PA) in TBS (DPBS with
0.5% Triton X-100 (Sigma) and 0.1% sodium azide (Sigma), pH
7.2) at 4 C overnight to decrease nonspeciﬁc labeling.
The free-ﬂoating sections were incubated with primary anti-
bodies at 4 C for 4 days in the presence of 3% donkey serum-
TBS. Controls lacking primary antibodies were also processed. After
several rinses, the sections were transferred and incubated over-
night in 3% normal donkey serum-TBS solution containing don-
key-hosted secondary antibodies conjugated with Cy5, Cy3
(1:200, Jackson Immunoresearch), or Alexa Fluor 488 (1:200,
Molecular Probes, Eugene, OR) at 4 C. After rinsing several times,
the sections were mounted with Vectashield medium (Vector Lab-
oratories, Burlingame, CA) and coverslipped before being observed
with a confocal laser scanning microscope (LSM 510; Zeiss, Thorn-
wood, NY). Images were acquired using 40 and 63 oil-immer-
sion objectives with Zeiss LSM software. Adobe Photoshop CS5
(Adobe Systems, San Jose, CA) was then used to crop images and
uniformly apply identical brightness and contrast adjustments.3. Results
3.1. Effects of exogenous glutamate on ERG in dark-adapted living
mouse eyes
To establish the baseline potency of injected glutamate in inhib-
iting signal transmission, GLU was dissolved in saline and injected
into the eyes of 30 mice. It was found that the exogenously intro-
duced neurotransmitter inhibited the ERG b-wave (which origi-
nates from DBCs) shortly after its introduction. As shown in
Fig. 1A, b-wave was inhibited the most at the 5 min post-injection
time point and then recovered gradually during the 1 h window for
all stimulus strengths. Using the baseline data established in
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ized according to their corresponding stimulus strength and
recorded time to compensate for artifactual effects of puncturing
the eye and injecting saline. For example, amplitudes of the ERG
in GLU injected eyes were normalized using Eq. (1) in the method
Section 2.3.
The dose–response relationship between GLU concentration
and b-wave amplitude was then determined using a titrating
experimental approach, in which various concentrations of GLU
were injected before ERG was measured. The data at the 5 min
time point was chosen, when the inhibition was maximum, for
the above purpose. Fig. 1B illustrates the residual b-wave ampli-
tude against stimulus strength after injecting various concentra-
tions of GLU. To facilitate dissection of the rod/cone pathways
the stimulus strength is divided into four different zones (Abd-
El-Barr et al., 2009), which correspond to the operating ranges of
different retinal neurons including rod, cone, DBCR, DBCC and AII
amacrine cells (Fig. 1C). For simplicity, zones I and II together
may be regarded as scotopic zones, while zone III and IV may be
respectively regarded as mesopic and photopic. Full inhibition of
the b-wave was observed when measured with a zone III moderate
stimulus but not with a weaker zone II or a stronger zone IV stim-
ulus. The b-wave in zone III is most susceptible to the inhibition by
exogenous GLU.
The amplitude of the b-wave is then normalized and plotted
against the retinal concentration of GLU in Fig. 2A–C at three differ-
ent representative stimulus strengths. As read from the drop-lines,
GLU has IC50 values of 4.47, 3.58 and 4.21 log lM (or 29 mM,
3.8 mM and 16 mM in linear scale) at stimulus strengths of 6.2,
1.8 and 0.1 log R*/Rod, respectively. Corresponding IC50 values
for LAP4 tested under the same conditions were 1.57, 0.32 and
0.65 log lM (37, 2.1 and 4.5 lM), as described in Section 3.2 of
the companion paper. The IC50 values are deﬁned as the concen-
tration of a molecule that inhibits 50% of the measured response.
The fact that IC50GLUs were higher than IC50LAP4s suggests that
GLU is less potent than LAP4 on inhibiting the b-wave.
There is no evidence that the GLU dose-dependent inhibition of
b-wave was caused by a suppressed phototransduction. GLU inhib-
ited the b-wave without systematically affecting the a-wave. As
shown in Fig. 2D and E, increasing the concentration of GLU pro-
duced more variation but not a stronger or a systematic inhibition
on the amplitude of a-wave. Because a-waves normally manifest as
a PIII component truncated by a PII component (Granit, 1933), it is
likely that GLU increased the variation of the a-wave through sup-
pressing the b-wave.
3.2. Effects of EAAT2 and EAAT1 blockers on ERG
To determine the role of EAAT2 and EAAT1 on the uptake of
endogenous synaptic GLU, their blockers were injected into the
mouse eye. Injected EAAT2 speciﬁc blocker dihydrokainic acid
(130-fold selective for EAAT2 over EAAT1) partially inhibited the
b-wave only when its concentration was high (Fig. 3A and B).
The time course of inhibition differed depending on the stimulus
strength (Fig. 3A). For stimuli of 0.6 log R*/Rod or stronger, b-wave
amplitudes decreased with time and were the lowest at the 50 min
point. For stimuli of 0.1 log R*/rod or weaker, b-wave amplitudes
were the lowest at the beginning and increased over the 50 min
period measured. The inhibitory effects of dihydrokainic acid
(DHK) on the b-wave were studied using a titrating experimental
approach to establish the dose–response relationship. Twenty-six
mice were injected with various concentrations of DHK and then
ERG was used to monitor its effect on retinal functions. Data from
the time point when inhibitions were at maximumwere chosen for
plotting the dose–response curves in Fig. 3C–E, at three stimulus
strengths. DHK has IC50 values of 4.02, 4.30 and 4.67 log lM (10,20 and 47 mM in linear scale) at stimulus strengths of 6.2, 1.8
and 0.1 log R*/rod, respectively. It partially inhibited amplitudes
of the b-wave by 39%, 40% and 62% respectively at the above stim-
ulus strengths.
DHK had little effect on the amplitude of the a-wave and had a
minor effect on increasing the latency of a-wave when it inhibited
the b-wave, as illustrated in the representative raw ERG traces in
Fig. 4A. Such effects were not so dose-dependent (Fig. 4B and C).
Six mice were injected with UCPH (a potent selective EAAT1
blocker) of 400 lM retinal concentration in one eye, while another
six mice were injected with the solvent DMSO. It was found that
amplitudes of the b-wave were partially inhibited by UCPH, and
that the inhibition developed slowly in the ﬁrst 24 h after injection
and recovered signiﬁcantly after another 9 days (Fig. 5A). Inhibi-
tion was not observed during the ﬁrst hour. Minor inhibition was
detected 2 h after injection. At the 24th hour, injected eyes have
mean b-wave inhibited by 41–27% relative to the fellow eye. UCPH
produced 14–30% signiﬁcantly stronger inhibitions than those of
the DMSO. Inhibition was most prominent in zone II. There were
no signiﬁcant differences between UCPH and DMSO injected eyes
in the amplitudes of the a-wave. Higher retinal concentration of
UCPH was not tested because of the limited solubility of UCPH in
DMSO, and the limited volume of DMSO that can be injected into
the eye without affecting the b-wave.
3.3. Effects of co-injecting EAAT inhibitors and glutamate
To study the contribution of EAAT2 to the glutamate clearing
activity in the photoreceptor-DBC synapse, glutamate (GLU) was
co-injected with a threshold retinal concentration (200 lM or 2.3
log lM) of DHK. According to our earlier data (Fig. 3B–E), this con-
centration of DHK inhibited amplitudes of the b-wave by 10–23%
at the 5 min time point depending on the stimulus strength.
The above paradigm was repeated in another group of mice
using a threshold retinal concentration (0.5 lM or 0.3 log lM)
of TBOA, which is a non-speciﬁc EAAT blocker commonly used to
study the effect of blocking EAAT5. In Section 3.3 of our companion
paper, we have shown that TBOA inhibited the ERG b-wave in a
dose-dependent manner similar to that of GLU or TBOA. The above
threshold concentration of TBOA was found to inhibit the ampli-
tude of the b-wave by 16–23% at various stimulus levels. The
dose–response curves for GLU in the presence of DHK or TBOA
(Fig. 6) were tested and modeled under the conditions described
above. To isolate the effect of GLU, data were normalized to com-
pensate for the minor inhibitory effects of DHK or TBOA with the
following sample equation:
normalized b-waveGLU;DHK ¼ b-waveGLU;DHKb-waveuninjected fellow eye
Mean b-waveuninjected control eye
Mean b-wave200 lM DHK
ð2Þ
As shown in Figs. 1B and 2A–C, intravitreally injected GLU pro-
duced the most inhibition of the b-wave measured with a zone III
stimulus of log 1.8 R*/Rod, and lesser percentages of inhibition
when measured with a weaker or a stronger stimuli. This inhibi-
tory pattern was preserved when GLU was co-injected with either
DHK or TBOA. The IC50 values for GLU were, however, quite differ-
ent between mice injected with the two EAAT inhibitors. Under the
strongest stimulus GLU had a lower value of 1.95 log lM (92 lM)
in the presence of DHK compared to the higher value of
4.25 log lM (18 mM) in the presence of TBOA (Fig. 6A and B).
The difference was 2.3 log units. Similar differences of 2.79 log u-
nits (1.24 versus 4.03 log lM) and 2.67 log units (1.58 versus
4.25 log lM) were found, respectively, using a moderate zone III
stimulus (Fig. 6C and D) and a weaker zone II stimulus (Fig. 6E
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Fig. 2. (A–C) Dose–response curves showing the amplitude of b-wave against log concentration of GLU measured at three different stimulus levels. Individual data points and
error bars denote value mean and standard error, respectively. Values in black and gray beside the vertical drop-lines represent IC50 and EC50, respectively. (A) Curve
measured with a strong rod-saturating zone IV stimulus within the operating range of cones. b-Wave was inhibited by 67% with highest concentrations of GLU. (B) Curve
measured with a moderate zone III stimulus. The b-wave was almost completely inhibited (96%) when concentrations were high enough. (C) Curve measured with a weaker
zone II stimulus. The b-wave was greatly inhibited by the highest concentrations of GLU, with a residual of about 27%. (D and E) Scatterplots showing the normalized
amplitude of a-wave versus the concentration of GLU measured with (D) a strong stimulus of 6.2 log R*/Rod or (E) a moderate stimulus of 1.8 log R*/Rod. The a-wave
amplitude became more variable when GLU concentrations were high. The slopes for the linear regression lines were 0.008 and 0.099, quite close to zero, indicating that the
amplitude of a-wave did not correlate with the concentration of GLU.
54 D.Y. Tse et al. / Vision Research 103 (2014) 49–62and F). These ﬁndings suggested that applied 200 lM DHK has a
stronger effect than the applied 0.5 lM TBOA on increasing the
potency of exogenous GLU, possibly through blocking the activities
of membrane EAATs for removing free GLU.
By pooling the above data with the LAP4 data presented in Sec-
tion 3.2 of the companion paper, Fig. 7 compares the dose–
response curves of GLU under 3 different conditions (injected
alone, coinjected with DHK, or coinjected with TBOA) to the curve
of LAP4. As illustrated, LAP4 has IC50 values 2.9–3.6 log units smal-
ler than those of GLU. It is shown that GLU had its dose–response
curves shifted largely toward the left when coinjected with DHK.
The magnitudes of those left-shifts, when quantiﬁed using the
IC50 values, was most prominent in zone IV and was equivalent
to 86% of the difference in IC50 between GLU and LAP4. Equivalentshifts in IC50 were 72% and 74% in zone III and II, respectively.
These suggest that EAAT2, selectively inhibited by the applied
DHK, contributes to the removal of free synaptic glutamate in the
photoreceptor-DBC synapses particularly in the cone-DBC syn-
apses. These also indicate that the activity of EAAT2 was responsi-
ble for the difference between LAP4 and GLU in their potencies in
inhibiting the b-wave.
In contrast, the presence of a threshold dose of TBOA did not
consistently shift the GLU dose–response curve despite the fact
that TBOA is a known non-speciﬁc EAAT blocker. In our companion
paper, we have shown that TBOA effectively inhibited the b-wave
in a dose-dependent manner. 200 lM DHK or 0.5 lM TBOA inhib-
ited the b-wave by a similar percentage when injected alone. If
TBOA and DHK inhibited the b-wave through the same mechanism
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Fig. 3. (A) A line chart showing the changes in normalized b-wave amplitude 5–50 min after injecting DHK of 15 mM (retinal concentration). Lines represent corresponding
stimulus strengths in log photoisomerizations per rod (R*/rod). Two different trends were observed. First, b-wave amplitudes decreased with time and were the lowest at the
50 min point for stimuli (solid lines) of 0.6 log R*/rod or stronger. This implies that DHK inhibited the b-wave through a slow acting mechanism in this stimulus range. Second,
b-wave amplitudes were the lowest at the 5 min point and increased with time for stimulus strengths (dotted lines) between 0.6 and 0.1 log R*/rod. This implies that DHK
inhibited the b-wave through a fast acting mechanism in that range. (B) Injected 0.2 mM DHK has a small inhibitory effect on the normalized b-wave. (C–E) Dose–response
curves showing normalized amplitude of b-wave against log concentrations of DHK measured at three different stimulus levels. Individual data points and error bars denote
value mean and standard error, respectively. Values in black and gray beside the vertical drop-lines represent IC50 and EC50, respectively. Note that presented concentrations
were calculated by diluting the injected aliquot with the vitreous volume, without accounting for possible clearance overtime. (C) Curve measured with a strong rod-
saturating zone IV stimulus within the operating range of cones 50 min after injection. Mean b-wave was inhibited by 39% with the highest concentration. (D) A curve ﬁtted
using data measured with a moderate zone III stimulus 50 min after injection. Mean b-wave was inhibited by 40–44% with the two highest concentrations. (E) A curve ﬁtted
using data measured with a weaker zone II stimulus 5 min post-injection. Mean b-wave was inhibited by 62% with the highest concentration.
D.Y. Tse et al. / Vision Research 103 (2014) 49–62 55(blocking synaptic glutamate clearing), then co-injecting GLU with
them at their respective threshold concentrations should have
shifted the respective measured GLU dose–response curves. Our
ﬁnding that such left-shifting occurred only in the presence of
DHK but not TBOA indicates that TBOA inhibited the b-wave
through a different mechanism when applied at the selected lowconcentration, without signiﬁcantly affecting the clearing activity
for free synaptic GLU. Such mechanism was studied in our
companion paper and was found to be mediated by the blockage
of postsynaptic EAAT5-coupled chloride channels on the DBCs.
We did not study the effect of coinjecting GLU with a high
concentration TBOA. It is expected that the clearing activity for
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Fig. 4. (A) Representative raw wave traces showing a- and b-wave from an
uninjected eye (black) and an eye injected with 15 mM retinal concentration of
DHK. A consistent, large reduction in the amplitude of the b-wave was observed
together with a minor reduction in the amplitude of the a-wave and signiﬁcant
increased latency of a-wave. (B) Scatterplot showing the normalized amplitude of a-
wave versus log concentration of DHK measured with a zone III stimulus of
1.8 log R*/Rod. The slope for the linear regression line was 0.059, indicating that
the amplitude of a-wave did not change with the concentration of those agonists.
(C) Scatterplot showing the normalized latency of a-wave versus log concentration
of DHK measured with a zone III stimulus. The slope for the linear regression lines
were 0.113, indicating that the latency of the a-wave barely increases with the
concentration of DHK.
56 D.Y. Tse et al. / Vision Research 103 (2014) 49–62free synaptic GLU will be affected if TBOA is applied in high
concentrations.3.4. Immunohistochemistry
To anatomically identify and localize the hardware underlying
the observed DHK-sensitive glutamate removal mechanism, a ser-
ies of IHC experiments were performed using a combination of
antibodies that label different neurons in the OPL. Fig. 8A shows
that EAAT2a immuno-reactivity is present in multiple layers of
the retina and is most prominent in the OPL. Fig. 8B shows that
EAAT2a was not present on the presynaptic active zone of the cone
pedicles. Fig. 8C shows that EAAT2a co-localized with PSD95 and
suggested its presence on the rod terminal spherules. The absence
of EAAT2a staining below the cone pedicles (Fig. 8D) indicated that
DBCC dendrites post-synaptic to cones did not express EAAT2a. In
contrast, the ﬁnding that EAAT2a co-localized with PKCa sug-
gested its presence on DBCR dendrites (Fig. 8E–G).
EAAT2b immuno-reactivity was also most prominent in the OPL
(Fig. 9A). Different from that of EAAT2a, EAAT2b was shown to be
present on the active zone of cone pedicles (Fig. 9B and C). It was
found in the distal half of the OPL staining numerous spherical
shapes, resembling rod spherules, but not in the other half of the
OPL proximal to the cone pedicles (Fig. 9B). EAAT2b appeared to
be absent from DBCCs and DBCRs as no obvious colocalization with
PKCa or Goa was observed (Fig. 9C and D).
4. Discussion
The present paper is the ﬁrst to study the in-vivo glutamate
clearing activity of EAATs in intact living mouse retina, by taking
advantage of an infrared illuminated microinjection system, the
non-invasive ERG technique and the newly available EAAT1 spe-
ciﬁc blocker UCPH101.
4.1. EAAT2 contributes substantially to the GLU clearing activity in
photoreceptor output synapses
We showed that the ERG b-wave was suppressed immediately
after injection of exogenous GLU, and recovered gradually after-
ward. The IC50 value for such GLU induced inhibition was found
to be 3.58 log lM, which was 3.26 log units higher than that of
LAP4 measured with a zone III stimulus (Fig. 7B). Except for the
above difference in potency, the patterns of GLU and LAP4 inhibi-
tion on the b-wave appeared qualitatively similar. This likely
implies that GLU and LAP4 inhibited the b-wave through the same
mechanism (saturating mGluR6) at the photoreceptor-DBC syn-
apse, and that the lower potency of glutamate was possibly due
to the selective afﬁnity of EAATs for GLU but not LAP4. Because
the ERG b-wave is generated by DBCs receiving synaptic input
from the photoreceptors, the differences in their dose–response
curves or IC50 values are likely indirect quantitative measures
for the glutamate clearing activity at the photoreceptor synapse
and along the diffusion pathway from the injected site to the syn-
apse. The ﬁrst line of evidence supporting this notion is provided
by our IHC results, which conﬁrmed the presence of EAAT2b on
cone terminals, and the presence of EAAT2a, EAAT2b and EAAT5
(see companion paper for EAAT5 ﬁndings) on rod terminals.
Furthermore, coinjecting a low concentration (0.2 mM) of DHK
(a EAAT2 blocker) with GLU increased the potency of GLU drasti-
cally for inhibiting the b-wave. As illustrated in Fig. 7, the resultant
GLU dose–response curve left-shifted to an extent more than half
of the total difference between GLU and LAP4 for all three stimulus
strengths when compared using the IC50 values. This second line
of evidence strongly indicates that the glutamate clearing activity
in both rod-DBC and cone-DBC synapses have been largely neutral-
ized by DHK, and that the underlying EAAT subtype was the DHK-
sensitive EAAT2. Moreover, the left-shifting of IC50GLU was most
obvious in zone IV (Fig. 7A) where the left-shifted IC50GLU became
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Fig. 5. (A) Changes of normalized b-wave amplitude over time after applying 400 lM (retinal concentration) UCPH-101. Lines represent corresponding strengths of stimulus
in log R*/Rod. Normalized b-wave amplitudes decreased with time and were the lowest at the 24th hour. The b-wave recovered mostly by the 10th day. ERGs on the right are
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asterisks (p < 0.05) or double asterisks (p < 0.01). Compared to DMSO controls, UCPH signiﬁcantly inhibited the b-wave in zones II, III and IV, with the strongest inhibition in
zone II. In contrast, it did not signiﬁcantly inhibit amplitudes of the a-wave.
D.Y. Tse et al. / Vision Research 103 (2014) 49–62 57insigniﬁcantly different from the IC50LAP4. This correlates well with
our IHC results which showed that cone presynaptic active zones
express only EAAT2, while rod presynaptic active zones express
both EAAT2 and EAAT5. The absence of a second EAAT type on cone
terminals may have rendered its GLU clearing capacity more sus-
ceptible for DHK.
4.2. Selective inhibition of EAAT1 but not EAAT2 disrupts GLU
equilibrium in photoreceptor synapses and reduces the b-wave
Our data showed that temporarily blocking EAAT1 using
injected UCPH partially inhibited the b-wave. Compared to other
EAAT blockers, the effect of UCPH was slower.It is possible that the slow time course of UCPH inhibition was a
result of slower migration of UCPHmolecule form the injection site
to the Muller cells. Unlike the other tested drugs, UCPH is soluble in
DMSO, poorly soluble in water, and has a heavier molecular weight
(UCPH: 422, DHK: 215, TBOA: 239). Partial reductions in the b-wave
amplitudes, similar to those produced by UCPH, have also been
reported previously when EAAT1 was being suppressed perma-
nently through genetic knockout (Harada et al., 1998) or by anti-
sense oligonucleotide administration (Barnett & Pow, 2000).
Inhibition on the ERG b-wave produced by injecting antisense oli-
gonucleotide was also slow. In mouse retina, EAAT1 is not present
on photoreceptor terminals but onMüller cells, which wrap around
the photoreceptor-DBC synapse. It may function as a GLU reuptake
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Fig. 6. Dose–response curves showing amplitudes of b-wave against log concentration of GLU measured at three different stimulus levels in the presence of either EAAT
inhibitor. Individual data points and error bars denote value mean and standard error, respectively. Data were normalized to controls in which a threshold dose of the selected
EAAT inhibitor, DHK or TBOA, was solely injected. Values in black and gray beside the vertical drop-lines represents IC50 and EC50, respectively. (A and B) Dose-response
curves measured with a strong rod-saturating zone IV stimulus within the operating range of cones. Using the highest concentration of GLU, the b-wave was inhibited by
maximums of 76% and 69% when co-injected with DHK and TBOA, respectively. (C and D) Curves measured with a moderate zone III stimulus. The b-wave was inhibited by
maximums of 89% and 95%, nearly abolished, when co-injected with DHK and TBOA, respectively. (E and F) Curves measured with a weaker zone II stimulus. The b-wave was
largely reduced by about 85% and 75% when co-injected with DHK and TBOA, respectively. At all three stimulus strengths, GLU had lower EC50 and IC50 values when co-
injected with DHK, compared to those co-injected with TBOA.
58 D.Y. Tse et al. / Vision Research 103 (2014) 49–62mechanism in the synapse, and its inhibition may have led to the
accumulation of endogenous GLU in the synapse, or a perturbed
glutamate–glutamine recycling between Müller cells and photore-
ceptors (Pow & Robinson, 1994), and subsequently an inhibition of
the b-wave. An alternative explanation for the slow action of UCPH
is that accumulation of synaptic GLU was slow, when the other
EAATs at the synapse remained functional.
In contrast, blocking EAAT2 alone did not signiﬁcantly inhibit
the b-wave. Our data showed that 0.2 mM DHK effectively shifted
the GLU dose–response curve when co-injected, but has little effect
on the b-wave when injected alone. This suggests that blocking
EAAT2 alone does not cause accumulation of endogenous GLU in
the photoreceptor-DBC synapse in the presence of functional
EAAT1. The fact that selectively blocking EAAT1 produced strongerinhibition on the b-wave than selectively blocking EAAT2 is
intriguing, because EAAT2 has a similar afﬁnity for GLU (Arriza
et al., 1994), a faster turnover rate (Bergles & Jahr, 1998;
Wadiche & Kavanaugh, 1998) compared to EAAT1, and is located
closer to the GLU release site. One possible explanation is that
the total number of EAAT1 transporters may be much higher than
that of EAAT2 at the synapse, so that its blockage resulted in a
higher impact on the overall GLU removing capacity and the accu-
mulation of GLU.
A higher concentration of DHK (15 mM) inhibited the ERG b-
wave though when injected alone. At higher stimulus levels within
the operational range of cones, inhibition was weaker at the begin-
ning but developed gradually with time during the 1 h period
tested (Fig. 3A). A different time course was observed at lower
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Fig. 7. Integrated line charts showing dose-response curves for LAP4, and for GLU
under different conditions, at three levels of stimulus strength. Individual data
points were not displayed to keep the ﬁgures clear. The numbers and error bars on
individual curves denote the IC50 values and standard errors, respectively. (A)
Dose–response curves measured with a strong rod-saturating zone IV stimulus.
LAP4 has an IC50 value 2.9 log units lower than that of GLU. The presence of DHK
shifts the GLU curve to the left and signiﬁcantly (p < 0.01) reduces the IC50 value
from 4.47 to 1.96 log lM (86% of the total difference between IC50GLU and IC50LAP4).
There was no difference between IC50LAP4 and IC50GLU+DHK (p > 0.05). Coinjecting
with TBOA did not signiﬁcantly shift the IC50 value for GLU (p > 0.05). (B) Dose–
response curves measured with a moderate zone III stimulus. LAP4 has an IC50
value 3.2 log units lower than that of GLU. The presence of DHK shifts the GLU curve
to the left and signiﬁcantly (p < 0.01) reduces its IC50 from 3.58 to 1.24 log lM (72%
of the difference). TBOA has no signiﬁcant effect on IC50GLU. (C) Dose–response
curves measured with a scotopic zone II stimulus. LAP4 has an IC50 value
3.6 log units lower than that of GLU. The presence of DHK shifts the GLU curve to
the left and signiﬁcantly (p < 0.01) reduces its IC50 from 4.21 to 1.58 log lM (74% of
the difference), while TBOA has little effect on IC50GLU.
D.Y. Tse et al. / Vision Research 103 (2014) 49–62 59stimulus levels at which only rods were functional. Since we have
shown in the co-injection experiment that 0.2 mM DHK was very
effective in inhibiting the GLU clearing activity of EAAT2, this direct
inhibition of the b-wave by a higher concentration DHK probably
involved a second mechanism. Given that DHK is 130-fold more
selective for EAAT2 (Ki = 23 lM) over EAAT1 (KiP 3 mM), we pos-
tulate that DHK non-speciﬁc blocking of EAAT1 was responsible. In
our ERG results, the time course for inhibition of the b-wave was
much faster in the rod operative range. This may imply that rod-
DBC synapses, compared to cone-DBC synapses, are more depen-
dent on the EAAT1 on Müller cells to maintain its GLU equilibrium.
Alternatively, it is also possible that the fast onset inhibition of the
b-wave following injection resulted from a direct inhibition of
post-synaptic EAAT2a on DBCR by DHK. This blocked the EAAT
gated chloride channel in the dark, making the membrane resting
potential less hyperpolarized and subsequently reduced the b-
wave generated by the DBCR during the light-elicited depolariza-
tion. It has been reported that EAAT2 mediates a small but measur-
able chloride conductance (Wadiche et al., 1995a), compared to
that of EAAT5 (Arriza et al., 1997).
4.3. EAAT5 inhibited the b-wave without signiﬁcantly affecting the
glutamate clearing capacity
Our data has shown that the presence of co-injected TBOA did
not consistently shift the GLU dose–response curves. TBOA is a
known inhibitor for EAAT 1–5, and should have left-shifted the
GLU dose–response curve if it had functioned like DHK and blocked
the presynaptic EAATs in the synapse. The best explanation for this
result is that the applied TBOA concentration (0.5 lM) was too low
to effectively neutralize the GLU clearing capacity of EAATs in the
photoreceptor-DBC synapse. Given the fact that the same concen-
tration of TBOA inhibited the b-wave by 16–23% and 45–48% in
wildtype and bhlhb4 / mice, respectively, when injected alone
(see Section 3.3 of the companion paper), it is indicated that the
mechanism through which low concentration TBOA inhibited the
b-wave did not involve blockage of presynaptic EAATs and satura-
tion of synaptic GLU. EAAT5 is known for its dual functions of GLU
transporter and GLU-gated chloride channels (Arriza et al., 1997;
Sonders & Amara, 1996). We presented evidences in our compan-
ion paper that the above inhibition was mediated through the
EAAT5-coupled chloride channel on cone depolarizing bipolar cell
dendrites.
4.4. Rod-DBCc synapse is more susceptible to inhibition by exogenous
GLU
Our results have shown that the b-wave measured with zone III
stimuli was inhibited most strongly by exogenous GLU (Fig. 1B and
C). It has been previously characterized that the Rod-DBCc path-
way is particularly active at that intensity (Abd-El-Barr et al.,
2009). This indicates that the Rod-DBCC synapse is more suscepti-
ble to inﬂuence by exogenous GLU. One possible explanation for
this could be that the Rod-DBCC synapse has a weaker diffusion
barrier for exogenous molecules compared to other photorecep-
tor-to-DBC synapses.
4.5. Conclusion
The present study has provided electrophysiological, pharmaco-
logical and immunohistological evidences for the functions of
EAAT1 on Müller cells, EAAT2b on cone terminals, and the func-
tions of EAAT2a, EAAT2b and EAAT5 on rod terminals in intact
dark-adapted retinae of living mice. Selective inhibition of EAAT1
using a newly available blocker (UCPH101) has led to reductions
in the b-wave suggesting that the EAAT1 on Müller cells is neces-
Fig. 8. (A–D) Confocal micrographs of retina from wild-type mice processed for EAAT2a (red), PSD95 (blue) and PNA (green). (A) EAAT2a immuno-reactivity (IR) was most
prominent in the OPL, diffusely present in the IPL and sparsely present in the INL and ONL. The bracketed segment is presented in the next few panels at a higher
magniﬁcation. (B) EAAT2a IR did not overlap with the PNA staining, indicating that EAAT2a is not present on the presynaptic active zones of cone photoreceptors. (C) PSD95-
IR was present in the distal half of the OPL where it co-localized with EAAT2a staining. Regions denoted by arrows were further magniﬁed and presented in (D). (D) The
EAAT2a-negative cavities under the PNA staining suggest that EAAT2a is not present on the dendritic processes of DBCCs that are post-synaptic to cones. (E–G) A z-axis image
series of consecutive optical sections (1 lm apart) showing the colocalization of EAAT2a (red) and PKCa (green) on DBCR dendrites as yellow punctate staining.
Fig. 9. (A–C) Confocal microscopic images of retina fromwild-type mice processed for EAAT2b (red), Goa (blue) and PNA (green). (A) EAAT2b-IR presented prominently in the
OPL, and diffusely in the IPL without clear stratiﬁcation. Some of the somas (possible cones) in the ONL and INL were also stained. A segment of OPL is presented as (B) and (C)
at higher magniﬁcation. (B) EAAT2b-IR was present only in the half of the OPL that is distal to PNA staining. The dense spherically shaped staining in red is likely rod
terminals. On the other hand, overlapped staining of PNA and EAAT2b resulted in the yellow color on cone pedicles (arrows). (C) Goa-IR presented mainly in the half of the
OPL that is proximal to PNA staining. There was no obvious overlapping between Goa and EAAT2b staining, suggesting that EAAT2b is not present on the dendrites of DBCs.
(D) The lack of overlap between EAAT2b (red) and PKCa (green) staining suggests that EAAT2b is not present on DBCRs.
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D.Y. Tse et al. / Vision Research 103 (2014) 49–62 61sary to maintain proper photoreceptor-to-DBC signal transmission
by acting as the major GLU reuptake mechanism, which is charac-
terized by a slower turnover rate but an overall higher clearing
capacity. The b-wave was inhibited by selective inhibition of
EAAT1, but not selective inhibition of EAAT2, suggesting that
EAAT1 plays a dominating role in GLU reuptake in the synaptic
cleft. The clearing activity for exogenous GLU at the cone and rod
terminals can be neutralized largely by DHK, indicating that it is
mediated by EAAT2 at the photoreceptor-DBC synapse. The close
proximity of EAAT2 to the GLU release site and its higher turnover
rate imply a signiﬁcant role of EAAT2 in the timely reabsorption of
GLU to the photoreceptor terminal. Low concentration of non-spe-
ciﬁc EAAT blocker (TBOA) inhibited the b-wave without affecting
the GLU clearing activity, suggesting the presence of a TBOA-sensi-
tive postsynaptic receptor in the synapse.Grants
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